Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Most Cited Articles

The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

, 2016; 16(2): 80-88.

Gholamreza Azizi, Hassan Abolhassani, Mohammad Hosein Asgardoon, Javad Rahnavard, Majid Zaki dizaji, Reza Yazdani, Javad Mohammadi and Asghar Aghamohammadi


DOI: 10.2174/1871530316666160724214418








Immune-Neuroendocrine Dysregulation in Patients with Osteoarthritis: A Revision and a Pilot Study

, 2017; 17(1): 78-85.

Isabel Galvez, Silvia Torres-Piles, Maria D. Hinchado, Alberto Alvarez-Barrientos, Pilar Torralbo-Jimenez, Jorge Guerrero, Leticia Martin-Cordero and Eduardo Ortega*


DOI: 10.2174/1871530317666170320113613






Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.93



Related Journals

Related eBooks

eBooks Catalog